• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

D.Western Therapeutics Institute Inc

+ Add to Watchlist

4576:JP

907.0 JPY 16.0 1.73%

As of 01:00:00 ET on 01/27/2015.

Snapshot for D.Western Therapeutics Institute Inc (4576)

Open: 911.0 Day's Range: 906.0 - 923.0 Volume: 118,900
Previous Close: 923.0 52wk Range: 552.0 - 3,550.0 1-Yr Rtn: +9.67%

Stock Chart for 4576

No chart data available.
  • 4576:JP 909.0
  • 1D
  • 1M
  • 1Y
923.0
Interactive 4576 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4576

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -9.2500
Est. EPS (JPY) (12/2014) -
Est. PEG Ratio -
Market Cap (M JPY) 20,650.94
Shares Outstanding (M) 22.77
30 Day Average Volume 323,990
Price/Book (mrq) 9.6559
Price/Sale (ttm) 294.4865
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4576

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4576

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

Hiroyoshi HidakaChairman/Chief Scientist OfcrYuichi HidakaPresident/CEO
Tetsuya KawakamiDirector
More Company Profile & Key Executives for 4576

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil